Sun Pharmaceutical Industries
ABOUT US
Driven by a bold pursuit of science and fueled by an unwavering commitment to patients, Sun Pharma is a global pharmaceutical company providing high-quality medicines to people in need for more than four decades. As part of our mission to Reach People and Touch Lives, we deliver Innovative Medicines that improve the lives of millions of people. With a broadly diversified portfolio of products that span multiple therapeutic areas, we improve access to effective, affordable treatments that promote better health and well-being.
2 Independence Way
Princeton, NJ 08540
(609) 720-9200
sunpharma.com/usa
PRIMARY CONTACTS
Heather Rosati
National Account Director
(757) 572-7076
heather.rosati@sunpharma.com
Kunal Patel
Medical Director, Medical Affairs
(908) 936-6379
kunal.patel@sunpharma.com
PRODUCTS OR SERVICES
UNLOXCYT is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who are not candidates for curative surgery or curative radiation. UNLOXCYT™ (cosibelimab-ipdl) Injection 300 mg | cSCC Information
ODOMZO® (sonidegib) is a prescription medicine used to treat adults with basal cell carcinoma, that has come back following surgery or radiation or that cannot be treated with surgery or radiation. ODOMZO® (sonidegib) | For Healthcare Professionals
YONSA® (abiraterone acetate) in combination with methylprednisolone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC). YONSA® (abiraterone acetate) | Prescription Treatment for mCRPC